{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:40:43Z","timestamp":1785253243388,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["6145"],"award-info":[{"award-number":["6145"]}],"id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005633","name":"Syd\u00e4ntutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["230027"],"award-info":[{"award-number":["230027"]}],"id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004092","name":"Kuopion Yliopistollinen Sairaala","doi-asserted-by":"publisher","award":["Kuopion Yliopistollinen Sairaala"],"award-info":[{"award-number":["Kuopion Yliopistollinen Sairaala"]}],"id":[{"id":"10.13039\/501100004092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EJNMMI Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Corresponding to impaired insulin response in skeletal muscle, insulin resistance may occur in the myocardium, suggesting a link between cardiometabolic disorders and cardiac glucose metabolism. We aimed to investigate whether cardiometabolic disorders predict myocardial [<jats:sup>18<\/jats:sup>F]fluorodeoxyglucose ([<jats:sup>18<\/jats:sup>F]FDG) uptake suppression in cardiac positron emission tomography \/ computed tomography (PET\/CT) following a ketogenic diet and fasting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study included 100 patients undergoing [<jats:sup>18<\/jats:sup>F]FDG-PET\/CT following a ketogenic diet of 1\u20132 days and a 12\u00a0h fast. Blood glucose, insulin, \u03b2-hydroxybutyrate (BHB), cholesterol, triglycerides and free fatty acid (FFA) levels were measured before [<jats:sup>18<\/jats:sup>F]FDG injection and later off-diet following overnight fast. The homeostatic model assessment\u2013insulin resistance (HOMA-IR) value was calculated. Non-contrast computed tomography was used to assess the presence of fatty liver and visceral and subcutaneous fat areas. Suppression of myocardial [<jats:sup>18<\/jats:sup>F]FDG uptake was considered adequate if myocardial uptake was equal to or lower than the blood pool background. Compared to inadequate suppression, adequate suppression was associated with higher levels of BHB (median 0.26 mmol\/l for inadequate and 0.43 mmol\/l for adequate suppression, <jats:italic>p<\/jats:italic>\u2009=\u20090.004), FFA (0.58 mmol\/l and 0.76 mmol\/l respectively, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), triglycerides (0.87 mmol\/l and 1.12 mmol\/l respectively, <jats:italic>p<\/jats:italic>\u2009=\u20090.028), and lower liver-spleen attenuation ratios (1.17 and 1.04 respectively, <jats:italic>p<\/jats:italic>\u2009=\u20090.013). Low HDL cholesterol, high triglycerides and off-diet HOMA-IR, as well as visceral adiposity, fatty liver and hypertension, predicted adequate suppression in men. Elevated BHB and FFA were significant predictors of adequate suppression in women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Cardiometabolic disorders are associated with lower myocardial [<jats:sup>18<\/jats:sup>F]FDG uptake. Insulin resistance and several other cardiometabolic risk factors are associated with attenuated uptake, especially in men. In women, factors reflecting metabolic response to a ketogenic diet and fasting have a more pronounced effect on myocardial [<jats:sup>18<\/jats:sup>F]FDG uptake.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13550-025-01278-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:50:40Z","timestamp":1751363440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cardiometabolic disorders affect myocardial [18F]fluorodeoxyglucose uptake\u2013 impact on diagnostic PET\/CT imaging"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7718-5144","authenticated-orcid":false,"given":"Suvi","family":"Hartikainen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-2506","authenticated-orcid":false,"given":"Ville","family":"Veps\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3748-7580","authenticated-orcid":false,"given":"Tuomo","family":"Tompuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3361-096X","authenticated-orcid":false,"given":"Tiina M.","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1318-8287","authenticated-orcid":false,"given":"Marja","family":"Hedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3553-9957","authenticated-orcid":false,"given":"Tomi","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1278_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s12149-014-0840-y","volume":"28","author":"MA Ozguven","year":"2014","unstructured":"Ozguven MA, Karacalioglu AO, Ince S, Emer MO. Altered biodistribution of FDG in patients with type-2 diabetes mellitus. Ann Nucl Med. 2014;28:505\u201311.","journal-title":"Ann Nucl Med"},{"key":"1278_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12872-018-0943-9","volume":"18","author":"L Hu","year":"2018","unstructured":"Hu L, Qiu C, Wang X, Xu M, Shao X, Wang Y. The association between diabetes mellitus and reduction in myocardial glucose uptake: a population-based 18F-FDG PET\/CT study. BMC Cardiovasc Disord. 2018;18:203.","journal-title":"BMC Cardiovasc Disord"},{"key":"1278_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S1071-3581(00)70013-4","volume":"7","author":"I Yokoyama","year":"2000","unstructured":"Yokoyama I, Yonekura K, Ohtake T, Kawamura H, Matsumoto A, Inoue Y, et al. Role of insulin resistance in heart and skeletal muscle F-18 Fluorodeoxyglucose uptake in patients with noninsulin-dependent diabetes mellitus. J Nucl Cardiol. 2000;7:242\u20138.","journal-title":"J Nucl Cardiol"},{"key":"1278_CR4","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1007\/s12350-018-1446-x","volume":"27","author":"K Tang","year":"2020","unstructured":"Tang K, Zheng X, Lin J, Zheng M, Lin H, Li T, et al. Association between non-alcoholic fatty liver disease and myocardial glucose uptake measured by 18F-fluorodeoxyglucose positron emission tomography. J Nucl Cardiol. 2020;27:1679\u201388.","journal-title":"J Nucl Cardiol"},{"key":"1278_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12902-020-00556-x","volume":"20","author":"L Hu","year":"2020","unstructured":"Hu L, Shao X, Qiu C, Shao X, Wang X, Niu R, et al. Hepatic steatosis is associated with abnormal hepatic enzymes, visceral adiposity, altered myocardial glucose uptake measured by 18F-FDG PET\/CT. BMC Endocr Disord. 2020;20:75.","journal-title":"BMC Endocr Disord"},{"key":"1278_CR6","doi-asserted-by":"publisher","first-page":"E282","DOI":"10.1152\/ajpendo.00604.2005","volume":"291","author":"R Lautam\u00e4ki","year":"2006","unstructured":"Lautam\u00e4ki R, Borra R, Iozzo P, Komu M, Lehtim\u00e4ki T, Salmi M, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes. Am J Physiol-Endocrinol Metab. 2006;291:E282\u201390.","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"1278_CR7","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-015-0310-4","volume":"14","author":"G Kim","year":"2015","unstructured":"Kim G, Jo K, Kim KJ, Lee Y, Han E, Yoon H, et al. Visceral adiposity is associated with altered myocardial glucose uptake measured by 18FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes. Cardiovasc Diabetol. 2015;14:148.","journal-title":"Cardiovasc Diabetol"},{"key":"1278_CR8","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.2337\/dc23-0871","volume":"46","author":"A Devesa","year":"2023","unstructured":"Devesa A, Fuster V, Vazirani R, Garc\u00eda-Lunar I, Oliva B, Espa\u00f1a S, et al. Cardiac insulin resistance in subjects with metabolic syndrome traits and early subclinical atherosclerosis. Diabetes Care. 2023;46:2050\u20137.","journal-title":"Diabetes Care"},{"key":"1278_CR9","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1007\/s00259-020-05066-5","volume":"48","author":"RHJA Slart","year":"2021","unstructured":"Slart RHJA, Glaudemans AWJM, Gheysens O, Lubberink M, Kero T, Dweck MR, et al. Procedural recommendations of cardiac PET\/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM. Eur J Nucl Med Mol Imaging. 2021;48:1016\u201339.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1278_CR10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","volume":"58","author":"P Chareonthaitawee","year":"2017","unstructured":"Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL, et al. Joint SNMMI\u2013ASNC expert consensus document on the role of 18F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med. 2017;58:1341\u201353.","journal-title":"J Nucl Med"},{"key":"1278_CR11","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1007\/s00259-020-04713-1","volume":"47","author":"AM Scholtens","year":"2020","unstructured":"Scholtens AM, van den Berk AM, van der Sluis NL, Esser JP, Lammers GK, de Klerk JMH, et al. Suppression of myocardial glucose metabolism in FDG PET\/CT: impact of dose variation in heparin bolus pre-administration. Eur J Nucl Med Mol Imaging. 2020;47:2698\u2013702.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1278_CR12","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/0284185115600916","volume":"57","author":"A Masuda","year":"2016","unstructured":"Masuda A, Naya M, Manabe O, Magota K, Yoshinaga K, Tsutsui H, et al. Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart. Acta Radiol. 2016;57:661\u20138.","journal-title":"Acta Radiol"},{"key":"1278_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/cpf.12881","volume":"44","author":"S Hartikainen","year":"2024","unstructured":"Hartikainen S, Tompuri T, Laitinen T, Laitinen T. Point-of-care \u03b2-hydroxybutyrate measurement predicts adequate glucose metabolism suppression in cardiac FDG-PET\/CT. Clin Physiol Funct Imaging. 2024;44:349\u201358.","journal-title":"Clin Physiol Funct Imaging"},{"key":"1278_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412\u20139.","journal-title":"Diabetologia"},{"key":"1278_CR15","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1148\/radiol.10101233","volume":"258","author":"YS Park","year":"2011","unstructured":"Park YS, Park SH, Lee SS, Kim DY, Shin YM, Lee W, et al. Biopsy-proven nonsteatotic liver in adults: Estimation of reference range for difference in Attenuation between the liver and the spleen at nonenhanced CT. Radiology. 2011;258:760\u20136.","journal-title":"Radiology"},{"key":"1278_CR16","doi-asserted-by":"publisher","first-page":"656658","DOI":"10.3389\/fmed.2021.656658","volume":"8","author":"A Hokkanen","year":"2021","unstructured":"Hokkanen A, H\u00e4m\u00e4l\u00e4inen H, Laitinen TM, Laitinen TP. Test\u2013Retest reliability of the assessment of fatty liver disease using Low-Dose computed tomography in cardiac patients. Front Med. 2021;8:656658.","journal-title":"Front Med"},{"key":"1278_CR17","doi-asserted-by":"crossref","unstructured":"Irlbeck T, Massaro J, Bamberg F, O\u2019Donnell C, Hoffmann U, Fox C. Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham Heart Study. Int J Obes. 2005. 2010;34:781\u20137.","DOI":"10.1038\/ijo.2009.279"},{"key":"1278_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"K Alberti","year":"1998","unstructured":"Alberti K g. m. m. P z. P Zimmet 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15 539\u201353.","journal-title":"Diabet Med"},{"key":"1278_CR19","first-page":"1640","volume":"120","author":"KGMM Alberti","year":"2009","unstructured":"Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing Metabolic Syndrome Circulation. 2009;120:1640\u20135.","journal-title":"Harmonizing Metabolic Syndrome Circulation"},{"key":"1278_CR20","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Third Report of the National Cholesterol Education Program (NCEP)","year":"2002","unstructured":"Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation. 2002;106:3143\u20133143.","journal-title":"Circulation"},{"key":"1278_CR21","doi-asserted-by":"publisher","first-page":"e230083","DOI":"10.1148\/rg.230083","volume":"44","author":"K Kalisz","year":"2024","unstructured":"Kalisz K, Navin PJ, Itani M, Agarwal AK, Venkatesh SK, Rajiah PS. Multimodality imaging in metabolic syndrome: State-of-the-Art review. Radiographics. 2024;44:e230083.","journal-title":"Radiographics"},{"key":"1278_CR22","doi-asserted-by":"publisher","first-page":"924787","DOI":"10.3389\/fcvm.2022.924787","volume":"9","author":"E Succurro","year":"2022","unstructured":"Succurro E, Vizza P, Papa A, Cicone F, Monea G, Tradigo G, et al. Metabolic syndrome is associated with impaired Insulin-Stimulated myocardial glucose metabolic rate in individuals with type 2 diabetes: A cardiac dynamic 18F-FDG-PET study. Front Cardiovasc Med. 2022;9:924787.","journal-title":"Front Cardiovasc Med"},{"key":"1278_CR23","volume-title":"Guyton and hall textbook of medical physiology","author":"JE Hall","year":"2011","unstructured":"Hall JE. Guyton and hall textbook of medical physiology. 12th ed. Philadelphia, PA: Saunders\/Elsevier; 2011.","edition":"12"},{"key":"1278_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207\u201358.","journal-title":"Physiol Rev"},{"key":"1278_CR25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","volume":"133","author":"G Aubert","year":"2016","unstructured":"Aubert G, Martin OJ, Horton JL, Lai L, Vega RB, Leone TC, et al. The failing heart relies on ketone bodies as a fuel. Circulation. 2016;133:698\u2013705.","journal-title":"Circulation"},{"key":"1278_CR26","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122:624\u201338.","journal-title":"Circ Res"},{"key":"1278_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11897-023-00589-y","volume":"20","author":"SM Ng","year":"2023","unstructured":"Ng SM, Neubauer S, Rider OJ. Myocardial metabolism in heart failure. Curr Heart Fail Rep. 2023;20:63\u201375.","journal-title":"Curr Heart Fail Rep"},{"key":"1278_CR28","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jhep.2017.11.023","volume":"68","author":"Y Lee","year":"2018","unstructured":"Lee Y, Kim KJ, Yoo M, eun, Kim G, Yoon H, Jo K, et al. Association of non-alcoholic steatohepatitis with subclinical myocardial dysfunction in non-cirrhotic patients. J Hepatol. 2018;68:764\u201372.","journal-title":"J Hepatol"},{"key":"1278_CR29","doi-asserted-by":"crossref","unstructured":"Cefalo CMA, Riccio A, Fiorentino TV, Succurro E, Perticone M, Sciacqua A et al. Impaired insulin sensitivity measured by estimated glucose disposal rate is associated with decreased myocardial mechano-energetic efficiency in non-diabetic individuals. Eur J Intern Med [Internet]. 2024 [cited 2024 Nov 13]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0953620524003868","DOI":"10.1016\/j.ejim.2024.09.008"},{"key":"1278_CR30","first-page":"155","volume":"5","author":"LK Niskanen","year":"1991","unstructured":"Niskanen LK, Uusitupa MI, Py\u00f6r\u00e4l\u00e4 K. The relationship of hyperinsulinaemia to the development of hypertension in type 2 diabetic patients and in non-diabetic subjects. J Hum Hypertens. 1991;5:155\u20139.","journal-title":"J Hum Hypertens"},{"key":"1278_CR31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12933-024-02246-7","volume":"23","author":"E Succurro","year":"2024","unstructured":"Succurro E, Vizza P, Cicone F, Cassano V, Massimino M, Giofr\u00e8 F, et al. Sex-specific differences in myocardial glucose metabolic rate in non-diabetic, pre-diabetic and type 2 diabetic subjects. Cardiovasc Diabetol. 2024;23:144.","journal-title":"Cardiovasc Diabetol"},{"key":"1278_CR32","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1016\/j.ijcard.2013.03.016","volume":"168","author":"Y Kakinuma","year":"2013","unstructured":"Kakinuma Y, Okada S, Nogami M, Kumon Y. The human female heart incorporates glucose more efficiently than the male heart. Int J Cardiol. 2013;168:2518\u201321.","journal-title":"Int J Cardiol"},{"key":"1278_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.nuclcard.2007.03.001","volume":"14","author":"LR Peterson","year":"2007","unstructured":"Peterson LR, Soto PF, Herrero P, Schechtman KB, Dence C, Gropler RJ. Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol. 2007;14:573\u201381.","journal-title":"J Nucl Cardiol"},{"key":"1278_CR34","doi-asserted-by":"publisher","unstructured":"Kim Y, Kim D, Kim J, Yun M, Kang ES. Association between appendicular skeletal muscle mass and myocardial glucose uptake measured by 18F-FDG PET. ESC Heart Fail [Internet]. [cited 2024 Nov 13];n\/a. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/ehf2.15086","DOI":"10.1002\/ehf2.15086"},{"key":"1278_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1161\/01.CIR.95.2.415","volume":"95","author":"LH Young","year":"1997","unstructured":"Young LH, Renfu Y, Russell R, Hu X, Caplan M, Ren J, et al. Low-Flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation. 1997;95:415\u201322.","journal-title":"Circulation"},{"key":"1278_CR36","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1007\/s12350-023-03296-2","volume":"30","author":"S-H Chan","year":"2023","unstructured":"Chan S-H, Huang C-K, Luzhbin D, Hou P-N, Chang Y-T, Wu J. Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET\/CT. J Nucl Cardiol. 2023;30:2454\u201363.","journal-title":"J Nucl Cardiol"},{"key":"1278_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13550-024-01153-y","volume":"14","author":"S Hartikainen","year":"2024","unstructured":"Hartikainen S, Veps\u00e4l\u00e4inen V, Laitinen T, Hedman M, Laitinen T, Tompuri T. Heparin does not improve myocardial glucose metabolism suppression in [18 F]FDG PET\/CT in patients with low \u03b2-hydroxybutyrate level. EJNMMI Res. 2024;14:92.","journal-title":"EJNMMI Res"}],"container-title":["EJNMMI Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01278-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13550-025-01278-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13550-025-01278-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:50:43Z","timestamp":1751363443000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejnmmires.springeropen.com\/articles\/10.1186\/s13550-025-01278-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1186\/s13550-025-01278-8","relation":{},"ISSN":["2191-219X"],"issn-type":[{"value":"2191-219X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"17 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Kuopio University Hospital (16.8.2022\/1311). Written informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Financial interests: SH has received support from GE HealthCare to take part in the EACVI\/EANM Nuclear Cardiology Certification examination. Other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"80"}}